GANFORT

This brand name is authorized in Austria, Australia, Brazil, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug GANFORT contains a combination of these active pharmaceutical ingredients (APIs):

1 Bimatoprost UNII QXS94885MZ - BIMATOPROST

Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors. Read about Bimatoprost

2 Timolol UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma. Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10107Y, 10108B, 5558M, 9464D
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 501006301134319, 501006303171319, 501018100013603, 501018100013703, 501018100013803
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00265431, 00793360, 00793911, 06640172, 06640189, 06954002, 06954019, 09234998, 10738416, 10738422, 10744434, 11137392, 11218995, 11219003, 11282929, 11288010, 11288027, 11532220, 11532237, 12651636, 12801283, 13164743, 13352634, 13352640, 13651584, 13828195, 15621340, 16575926, 16992570, 16992587
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 362631012
Country: EE	Ravimiamet	Identifier(s): 1252976, 1252987, 1713866, 1713877, 1713888
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06340001, 106340004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 052405, 052414, 105470, 191091
Country: FR	Base de données publique des médicaments	Identifier(s): 60892664, 66489175
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 104583, 104584, 142466, 161827, 185799, 232966, 374388, 375919, 377475, 389422
Country: HK	Department of Health Drug Office	Identifier(s): 56429, 63183
Country: IE	Health Products Regulatory Authority	Identifier(s): 15460, 27506, 27518, 27520
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6663
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1005611, 1028637, 1071224, 1071225, 1071226
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 106798, 81108
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12264, 15688
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100160597
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51521001, W51521002
Country: SG	Health Sciences Authority	Identifier(s): 13589P, 14966P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3983021
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699490561126
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/15.4/0127